These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 21966264)

  • 41. Negative Epistasis and Evolvability in TEM-1 β-Lactamase--The Thin Line between an Enzyme's Conformational Freedom and Disorder.
    Dellus-Gur E; Elias M; Caselli E; Prati F; Salverda ML; de Visser JA; Fraser JS; Tawfik DS
    J Mol Biol; 2015 Jul; 427(14):2396-409. PubMed ID: 26004540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid in vivo evolution of a beta-lactamase using phagemids.
    Long-McGie J; Liu AD; Schellenberger V
    Biotechnol Bioeng; 2000 Apr; 68(1):121-5. PubMed ID: 10699880
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predicting the emergence of antibiotic resistance by directed evolution and structural analysis.
    Orencia MC; Yoon JS; Ness JE; Stemmer WP; Stevens RC
    Nat Struct Biol; 2001 Mar; 8(3):238-42. PubMed ID: 11224569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa.
    Barnes MD; Taracila MA; Rutter JD; Bethel CR; Galdadas I; Hujer AM; Caselli E; Prati F; Dekker JP; Papp-Wallace KM; Haider S; Bonomo RA
    mBio; 2018 Dec; 9(6):. PubMed ID: 30538183
    [No Abstract]   [Full Text] [Related]  

  • 45. OXA-48-Mediated Ceftazidime-Avibactam Resistance Is Associated with Evolutionary Trade-Offs.
    Fröhlich C; Sørum V; Thomassen AM; Johnsen PJ; Leiros HS; Samuelsen Ø
    mSphere; 2019 Mar; 4(2):. PubMed ID: 30918055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
    Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Infected foot ulcers in male and female diabetic patients: a clinico-bioinformative study.
    Shakil S; Khan AU
    Ann Clin Microbiol Antimicrob; 2010 Jan; 9():2. PubMed ID: 20070911
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detrimental effect of the combination of R164S with G238S in TEM-1 beta-lactamase on the extended-spectrum activity conferred by each single mutation.
    Giakkoupi P; Tzelepi E; Tassios PT; Legakis NJ; Tzouvelekis LS
    J Antimicrob Chemother; 2000 Jan; 45(1):101-4. PubMed ID: 10629019
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantifying the adaptive potential of an antibiotic resistance enzyme.
    Schenk MF; Szendro IG; Krug J; de Visser JA
    PLoS Genet; 2012 Jun; 8(6):e1002783. PubMed ID: 22761587
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A complex mutant of TEM-1 beta-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate.
    Sirot D; Recule C; Chaibi EB; Bret L; Croize J; Chanal-Claris C; Labia R; Sirot J
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1322-5. PubMed ID: 9174192
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutation supply and the repeatability of selection for antibiotic resistance.
    van Dijk T; Hwang S; Krug J; de Visser JAGM; Zwart MP
    Phys Biol; 2017 Aug; 14(5):055005. PubMed ID: 28699625
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative Description of a Protein Fitness Landscape Based on Molecular Features.
    Meini MR; Tomatis PE; Weinreich DM; Vila AJ
    Mol Biol Evol; 2015 Jul; 32(7):1774-87. PubMed ID: 25767204
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Concentration-dependent selection of small phenotypic differences in TEM beta-lactamase-mediated antibiotic resistance.
    Negri MC; Lipsitch M; Blázquez J; Levin BR; Baquero F
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2485-91. PubMed ID: 10952599
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High tolerance to simultaneous active-site mutations in TEM-1 beta-lactamase: Distinct mutational paths provide more generalized beta-lactam recognition.
    De Wals PY; Doucet N; Pelletier JN
    Protein Sci; 2009 Jan; 18(1):147-60. PubMed ID: 19177359
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Haemophilus influenzae bla(ROB-1) mutations in hypermutagenic deltaampC Escherichia coli conferring resistance to cefotaxime and beta-lactamase inhibitors and increased susceptibility to cefaclor.
    Galán JC; Morosini MI; Baquero MR; Reig M; Baquero F
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2551-7. PubMed ID: 12878518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contingency and chance erase necessity in the experimental evolution of ancestral proteins.
    Xie VC; Pu J; Metzger BP; Thornton JW; Dickinson BC
    Elife; 2021 Jun; 10():. PubMed ID: 34061027
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extended-spectrum β-lactamase-producing Escherichia coli contributes to the survival of cefotaxime-susceptible E. coli under high concentrations of cefotaxime by acquisition of increased AmpC expression.
    Nakayama T; Kawahara R; Kumeda Y; Yamamoto Y
    FEMS Microbiol Lett; 2018 Mar; 365(5):. PubMed ID: 29361027
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    Barnes MD; Winkler ML; Taracila MA; Page MG; Desarbre E; Kreiswirth BN; Shields RK; Nguyen MH; Clancy C; Spellberg B; Papp-Wallace KM; Bonomo RA
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089425
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Properties of mutant SHV-5 beta-lactamases constructed by substitution of isoleucine or valine for methionine at position 69.
    Giakkoupi P; Miriagou V; Gazouli M; Tzelepi E; Legakis NJ; Tzouvelekis LS
    Antimicrob Agents Chemother; 1998 May; 42(5):1281-3. PubMed ID: 9593168
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Occurrence of ST23 complex phylogroup A Escherichia coli isolates producing extended-spectrum AmpC beta-lactamase in a French hospital.
    Crémet L; Caroff N; Giraudeau C; Dauvergne S; Lepelletier D; Reynaud A; Corvec S
    Antimicrob Agents Chemother; 2010 May; 54(5):2216-8. PubMed ID: 20145079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.